240 related articles for article (PubMed ID: 30878072)
1. Emerging treatment trends in pediatric TB.
Sharma S
Indian J Tuberc; 2019 Jan; 66(1):214-217. PubMed ID: 30878072
[TBL] [Abstract][Full Text] [Related]
2. Emerging trends in microbiological diagnostics in children.
Sharma S; Singhal R; Sarin R; Myneedu VP
Indian J Tuberc; 2019 Oct; 66(4):549-554. PubMed ID: 31813447
[TBL] [Abstract][Full Text] [Related]
3. Patterns of drug resistance among patients with tuberculous pleural effusion in Greece.
Anastasakos V; Skouras V; Moschos C; Tsikrika S; Karabela S; Marinou I; Vogiatzakis E; Konstantinou K; Papavasiliou A; Kalomenidis I
Int J Tuberc Lung Dis; 2017 Mar; 21(3):309-313. PubMed ID: 28225341
[TBL] [Abstract][Full Text] [Related]
4. Recommendations for treating children with drug-resistant tuberculosis.
Galli L; Lancella L; Garazzino S; Tadolini M; Matteelli A; Migliori GB; Principi N; Villani A; Esposito S;
Pharmacol Res; 2016 Mar; 105():176-82. PubMed ID: 26821118
[TBL] [Abstract][Full Text] [Related]
5. [Fight against tuberculosis in the world].
El Kamel A; Joobeur S; Skhiri N; Cheikh Mhamed S; Mribah H; Rouatbi N
Rev Pneumol Clin; 2015; 71(2-3):181-7. PubMed ID: 24878188
[TBL] [Abstract][Full Text] [Related]
6. Management of multidrug resistant tuberculosis.
Daley CL; Caminero JA
Semin Respir Crit Care Med; 2013 Feb; 34(1):44-59. PubMed ID: 23460005
[TBL] [Abstract][Full Text] [Related]
7. Protocol for the management of newly diagnosed cases of tuberculosis.
Katiyar SK; Katiyar S
Indian J Tuberc; 2019 Oct; 66(4):507-515. PubMed ID: 31813442
[TBL] [Abstract][Full Text] [Related]
8. Current management of respiratory tuberculosis.
Ormerod P
Br J Hosp Med; 1987 Apr; 37(4):304-8. PubMed ID: 3580684
[TBL] [Abstract][Full Text] [Related]
9. Extensively Drug-resistant Tuberculosis (XDR-TB): A daunting challenge to the current End TB Strategy and policy recommendations.
Rahman MA; Sarkar A
Indian J Tuberc; 2017 Jul; 64(3):153-160. PubMed ID: 28709481
[TBL] [Abstract][Full Text] [Related]
10. [Surgical therapy of pulmonary tuberculosis].
Branscheid D; Albrecht CM; Diemel KD
Internist (Berl); 2003 Nov; 44(11):1406-12. PubMed ID: 14689076
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive cost of treating one patient with MDR/pre-XDR-TB in Wellington, New Zealand.
McNaughton A; Blackmore T; McNaughton H
Eur Respir J; 2016 Oct; 48(4):1256-1259. PubMed ID: 27694421
[No Abstract] [Full Text] [Related]
12. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.
Centers for Disease Control and Prevention (CDC)
MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162
[TBL] [Abstract][Full Text] [Related]
13. When students become patients: TB disease among medical undergraduates in Cape Town, South Africa.
Van der Westhuizen HM; Dramowski A
S Afr Med J; 2017 May; 107(6):475-479. PubMed ID: 28604316
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
15. Extensively drug-resistant tuberculosis in the United States, 1993-2007.
Shah NS; Pratt R; Armstrong L; Robison V; Castro KG; Cegielski JP
JAMA; 2008 Nov; 300(18):2153-60. PubMed ID: 19001626
[TBL] [Abstract][Full Text] [Related]
16. [Management of multidrug-resistant tuberculosis].
Tritar F; Daghfous H; Ben Saad S; Slim-Saidi L
Rev Pneumol Clin; 2015; 71(2-3):130-9. PubMed ID: 25153927
[TBL] [Abstract][Full Text] [Related]
17. Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance.
Lohrasbi V; Talebi M; Bialvaei AZ; Fattorini L; Drancourt M; Heidary M; Darban-Sarokhalil D
Tuberculosis (Edinb); 2018 Mar; 109():17-27. PubMed ID: 29559117
[TBL] [Abstract][Full Text] [Related]
18. Multi and extensively drug-resistant pulmonary tuberculosis: advances in diagnosis and management.
Pontali E; Visca D; Centis R; D'Ambrosio L; Spanevello A; Migliori GB
Curr Opin Pulm Med; 2018 May; 24(3):244-252. PubMed ID: 29470252
[TBL] [Abstract][Full Text] [Related]
19. Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB?
Dheda K; Cox H; Esmail A; Wasserman S; Chang KC; Lange C
Respirology; 2018 Jan; 23(1):36-45. PubMed ID: 28850767
[TBL] [Abstract][Full Text] [Related]
20. Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB.
Chan ED; Strand MJ; Iseman MD
Clin Infect Dis; 2009 Mar; 48(5):e50-2. PubMed ID: 19191632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
